Self-report measures in the assessment of antiretroviral medication adherence: Comparison with medication possession ratio and HIV viral load

Journal of the International Association of Providers of AIDS Care

Volumn 14, Issue 2, 2015, Pages 156-162

  Kabore, Lassane ^a   Muntner, Paul ^a   Chamot, Eric ^a   Zinski, Anne ^b   Burkholder, Greer ^b   Mugavero, Michael J ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

adherence; antiretroviral therapy; HIV; medication possession ratio

Indexed keywords

ADULT; ANTIVIRAL THERAPY; ARTICLE; ETHICS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LIKERT SCALE; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MEDICATION POSSESSION RATIO; PATIENT ATTITUDE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SENSITIVITY AND SPECIFICITY; VIRUS LOAD; VISUAL ANALOG SCALE; COHORT ANALYSIS; COMPARATIVE STUDY; DRUG EFFECTS; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIDDLE AGED; PHYSIOLOGY; PSYCHOLOGY; VIROLOGY;

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADULT; ANTI-HIV AGENTS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; SELF REPORT; VIRAL LOAD;

EID: 84925128708     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957414557263     Document Type: Article

References (28)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005 ; 353 (5). 487-497
2. Messou E, Chaix M-L, Gabillard D, et al. Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Côte d'Ivoire. J Acquir Immune Defic Syndr. 2011 ; 56 (4). 356-364
3. Fielding KL, Charalambous S, Stenson AL, et al. Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study. BMC Infect Dis. 2008 ; 8: 93
4. Chesney MA, Ickovics JR, Chambers DB, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care. 2000 ; 12 (3). 255-266
5. MachtingerELBangsbergDR. Adherence to HIV Antiretroviral Therapy [Internet]. 2006. Web site. http://hivinsite.ucsf.edu/insite?page=kb-03-02-09. Accessed August 26, 2012.
6. Ickovics JR, Cameron A, Zackin R, et al. Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370. Antivir Ther. 2002 ; 7 (3). 185-193
7. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998 ; 279 (24). 1977-1983
8. Bangsberg DR. Preventing HIV antiretroviral resistance through better monitoring of treatment adherence. J Infect Dis. 2008 ; 197: S272 - S278
9. Bershteyn A, Eckhoff PA. A model of HIV drug resistance driven by heterogeneities in host immunity and adherence patterns. BMC Syst Biol. 2013 ; 7: 11
10. Parienti JJ, Massari V, Descamps D, et al. Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy. Clin Infect Dis. 2004 ; 38 (9). 1311-1316
11. Miller LG, Hays RD. Adherence to combination antiretroviral therapy: synthesis of the literature and clinical implications. AIDS Read. 2000 ; 10 (3). 177-185
12. Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999 ; 21 (6). 1074-1090
13. Fairman K, Motheral B. Evaluating medication adherence: which measure is right for your program?. J Manag Care Pharm. 2000 ; 6 (6). 499-504
14. Arnsten JH, Demas PA, Farzadegan H, et al. Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring. Clin Infect Dis. 2001 ; 33 (8). 1417-1423
15. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS Lond Engl. 1999 ; 13 (9). 1099-1107
16. UAB 1917 Clinic COHORT [Internet]. Web site. http://www.uab1917cliniccohort.org/. Accessed August 26, 2012.
17. Kozak MS, Mugavero MJ, Ye J, et al. Patient reported outcomes in routine care: advancing data capture for HIV cohort research. Clin Infect Dis. 2012 ; 54 (1). 141-147
18. Godwin NC, Willig JH, Nevin CR, et al. Underutilization of the AIDS Drug Assistance Program: associated factors and policy implications. Health Serv Res. 2011 ; 46 (3). 982-995
19. Feldman BJ, Fredericksen RJ, Crane PK, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2013 ; 17 (1). 307-318
20. Mugavero M, Ostermann J, Whetten K, et al. Barriers to antiretroviral adherence: the importance of depression, abuse, and other traumatic events. AIDS Patient Care STDs. 2006 ; 20 (6). 418-428
21. Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004 ; 57 (10). 1107-1110
22. McMahon JH, Jordan MR, Kelley K, et al. Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring. Clin Infect Dis. 2011 ; 52 (4). 493-506
23. Hong SY, Jerger L, Jonas A, et al. Medication possession ratio associated with short-term virologic response in individuals initiating antiretroviral therapy in namibia. PloS One. 2013 ; 8 (2). e56307
24. Goldman JD, Cantrell RA, Mulenga LB, Tambatamba BC, Reid SE, Levy JW, et al. Simple adherence assessments to predict virologic failure among HIV-infected adults with discordant immunologic and clinical responses to antiretroviral therapy. AIDS Res Hum Retroviruses. 2008 ; 24 (8). 1031-1035
25. Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009 ; 15 (1). 59-66
26. Fairley CK, Permana A, Read TRH. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting. HIV Med. 2005 ; 6 (5). 366-369
27. Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behav. 2006 ; 10 (3). 227-245
28. Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001 ; 134 (10). 968-977